The role of cell tropism for the pathogenesis of influenza in humans

Future Virology

Volumn 7, Issue 3, 2012, Pages 295-307

  Van Riel, Debby ^a   Kuiken, Thijs ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

cell tropism; influenza; pathogenesis; route of inoculation

Indexed keywords

ALPHA 2,3 LINKED SIALIC ACID; ALPHA 2,6 LINKED SIALIC ACID; HUMAN AIRWAY LIKE PROTEASE; IMPORTIN ALPHA1; IMPORTIN ALPHA3; IMPORTIN ALPHA7; KARYOPHERIN; MANNOSE BINDING LECTIN; PROTEINASE; SIALIC ACID DERIVATIVE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TMPRSS2 PROTEIN; TMPRSS4 PROTEIN; TRYPTASE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

ANTIBODY PRODUCTION; AVIAN INFLUENZA; BRONCHIOLE; BRONCHUS; CENTRAL NERVOUS SYSTEM DISEASE; CLARA CELL; CYTOKINE RESPONSE; ENDOSOME; EPITHELIUM CELL; GLYCOSYLATION; GOBLET CELL; HUMAN; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; INFLUENZA VIRUS A H9N2; LUNG ALVEOLUS MACROPHAGE; MUCUS; MYOCARDITIS; MYOPATHY; NONHUMAN; NOSE CAVITY; NOSE SEPTUM; PANDEMIC INFLUENZA; PNEUMONIA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RESPIRATORY TRACT MUCOSA; REVIEW; SEASONAL INFLUENZA; SIALYLATION; TRACHEA; TRACHEOBRONCHITIS; TROPISM; VIRUS ATTACHMENT; VIRUS PATHOGENESIS; ZOONOSIS;

AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 84858397811     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.12.11     Document Type: Review

References (97)

1. Wine JJ, Joo NS. Submucosal glands and airway defense. Proc. Am. Thorac. Soc. 1, 47-53 (2004).
2. Escada PA, Lima C, da Silva JM. The human olfactory mucosa. Eur. Arch. Otorhinolaryngol. 266, 1675-1680 (2009).
3. Colby TV, Yousem SA. Lungs. In:Histology for Pathologists Sternberg SS (Ed.). Lippincott-Raven, PA, USA, 433-458 (1997).
4. Lee RM, Forrest JB. Structure and function of cilia. In:The Lung: Scientific Foundations Crystal RG, West JB, Barnes PJ etal. (Eds). Raven Press, NY, USA 459-478 (1997).
5. Castranova V, Rabovsky J, Tucker JH, Miles PR. The alveolar type II epithelial cell: A multifunctional pneumocyte. Toxicol. Appl. Pharmacol. 93, 472-483 (1988).
6. Herzog EL, Brody AR, Colby TV, Mason R, Williams MC. Knowns and unknowns of the alveolus. Proc. Am. Thorac. Soc. 5, 778-782 (2008). n Provides an overview of the different cell types present and their function in the alveolus.
7. Gordon SB, Read RC. Macrophage defences against respiratory tract infections. Br. Med. Bull. 61, 45-61 (2002).
8. Lambrecht BN. Alveolar macrophage in the driver's seat. Immunity 24, 366-368 (2006).
9. Orgeig S, Hiemstra PS, Veldhuizen EJ etal. Recent advances in alveolar biology: Evolution and function of alveolar proteins. Respir. Physiol. Neurobiol. 83, 792-807 (2010).
10. Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses. In:Fields Virology -Volume 2 Knipe DM, Howley PM, Griffin DE etal. (Eds). Lippincott Williams & Wilkins, PA, USA 1691-1740 (2006).
11. Tateno I, Kitamoto O, Kawamura A Jr. Diverse immunocytologic findings of nasal smears in influenza. N. Engl. J. Med. 274, 237-242 (1966).
12. Nicholls JM, Chan MC, Chan WY etal. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 13(2), 147-149 (2007).
13. Shinya K, Ebina M, Yamada S etal. Avian flu: Influenza virus receptors in the human airway. Nature 440, 435-436 (2006).
14. Walsh JJ, Dietlein LF, Low FN, Burch GE, Mogabgab WJ. Bronchotracheal response in human influenza. Type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies. Arch. Intern. Med. 108, 376-388 (1961).
15. Hayden FG, Fritz R, Lobo MC etal. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101, 643-649 (1998).
16. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect. Dis. 5, 718-725 (2005). nn Discusses the mechanism of signs and symptoms that are associated with the common cold and influenza
17. Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine. 26(Suppl. 4), D59-D66 (2008).
18. Guarner J, Shieh WJ, Dawson J etal. Immunohistochemical and insitu hybridization studies of influenza A virus infection in human lungs. Am. J. Clin. Pathol. 114, 227-233 (2000).
19. Guarner J, Paddock CD, Shieh WJ etal. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin. Infect. Dis. 43, 132-140 (2006).
20. Kuiken T, van den Brand JM, van Riel D, Pantin-Jackwood MJ, Swayne DE. Comparative pathology of select agent influenza A virus infections. Vet. Pathol. 47, 893-914 (2010).
21. Gill JR, Sheng ZM, Ely SF etal. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch. Pathol. Lab. Med. 134, 235-243 (2010).
22. Sheng ZM, Chertow DS, Ambroggio X etal. Autopsy series of 68cases dying before and during the 1918 influenza pandemic peak. Proc. Natl Acad. Sci. USA 108, 16416-16421 (2011).
23. Beigel JH, Farrar J, Han AM etal. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353, 1374-1385 (2005).
24. Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol. 172, 1155-1170 (2008).
25. Uiprasertkul M, Puthavathana P, Sangsiriwut K etal. Influenza A H5N1 replication sites in humans. Emerg. Infect. Dis. 11, 1036-1041 (2005).
26. Gu J, Xie Z, Gao Z etal. H5N1 infection of the respiratory tract and beyond: A molecular pathology study. Lancet 370, 1137-1145 (2007).
27. Zeng H, Pappas C, Belser JA etal. Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: Possible involvement in the pathogenesis of human H5N1 virus infection. J. Virol. 86, 667-678 (2012).
28. Chan MC, Chan RW, Yu WC etal. Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Respir. Res. 10, 102 (2009).
29. Ocana-Macchi M, Bel M, Guzylack-Piriou L etal. Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells. J. Virol. 83, 12947-12955 (2009).
30. Palese P, Shaw ML. Orthomyxoviridae: The viruses and their replication. In:Fields Virology Knipe DM, Howley PM, Griffin DE etal. (Eds). Lippincott, Williams & Wilkins, PA, USA, 1647-1689 (2006).
31. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205, 17-23 (1994).
32. Suzuki Y. Sialobiology of influenza: Molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull. 28, 399-408 (2005).
33. Baigent SJ, McCauley JW. Influenza type A in humans, mammals and birds: Determinants of virus virulence, host-range and interspecies transmission. Bioessays 25, 657-671 (2003).
34. Zhang H. Tissue and host tropism of influenza viruses: Importance of quantitative analysis. Sci. China C Life Sci. 52, 1101-1110 (2009).
35. Imberty A, Gautier C, Lescar J etal. An unusual carbohydrate binding site revealed by the structures of two Maackia amurensis lectins complexed with sialic acid-containing oligosaccharides. J. Biol. Chem. 275, 17541-17548 (2000).
36. Couceiro JN, Paulson JC, Baum LG. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29, 155-165 (1993).
37. van Riel D, Munster VJ, de Wit E etal. H5N1 virus attachment to lower respiratory tract. Science 312, 399 (2006).
38. van Riel D, Munster VJ, de Wit E etal. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol. 171, 1215-1223 (2007).
39. Chandrasekaran A, Srinivasan A, Raman R etal. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 26, 107-113 (2008).
40. van Riel D, den Bakker MA, Leijten LM etal. Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am. J. Pathol. 176, 1614-1618 (2010).
41. Chutinimitkul S, Herfst S, Steel J etal. Virulence-associated substitution D222G in hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J. Virol. 84, 11813 (2010).
42. Childs RA, Palma AS, Wharton S etal. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol. 27, 797-799 (2009).
43. van Riel D, Leijten LM, van der EM etal. Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLoS Pathog. 7, E1002099 (2011).
44. de Wit E, Munster VJ, van Riel D etal. Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J. Virol. 84, 1597-1606 (2010).
45. Chan PK, Lee N, Joynt GM etal. Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus. J. Clin. Virol. 50, 320-324 (2011).
46. Mak GC, Au KW, Tai LS etal. Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. EuroSurveill. 15, 19534 (2010).
47. Rimmelzwaan GF, Kuiken T, Van Amerongen G etal. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol. 75, 6687-6691 (2001).
48. Kuiken T, Rimmelzwaan G, van Riel D etal. Avian H5N1 influenza in cats. Science 306, 241 (2004).
49. van Riel D, Rimmelzwaan GF, Van Amerongen G, Osterhaus AD, Kuiken T. Highly pathogenic avian influenza virus H7N7 isolated from a fatal human case causes respiratory disease in cats, but does not spread systemically. Am. J. Pathol. 177, 2185-2190 (2010).
50. Rimmelzwaan GF, van Riel D, Baars M etal. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am. J. Pathol. 168, 176-183 (2006).
51. Schrauwen EJA, Herfst S, Leijten LM etal. The multi basic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J. Virol. doi:10.1128/JVI.06828-11 (2012) (Epub ahead of print).
52. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N. Engl. J. Med. 363, 2233-2247 (2010).
53. Sleigh MA, Blake JR, Liron N. The propulsion of mucus by cilia. Am. Rev. Respir. Dis. 137, 726-741 (1988).
54. Debat H, Eloit C, Blon F etal. Identification of human olfactory cleft mucus proteins using proteomic analysis. J. Proteome Res. 6, 1985-1996 (2007).
55. Lamblin G, Boersma A, Klein A etal. Primary structure determination of five sialylated oligosaccharides derived from bronchial mucus glycoproteins of patients suffering from cystic fibrosis. The occurrence of the NeuAc alpha(2-3)Gal beta(1-4)[Fuc alpha(1-3)] GlcNAc beta(1.-) structural element revealed by 500-MHz 1H NMR spectroscopy. J. Biol. Chem. 259, 9051-9058 (1984).
56. Breg J, van Halbeek H, Vliegenthart JF etal. Structure of sialyl-oligosaccharides isolated from bronchial mucus glycoproteins of patients (blood group O) suffering from cystic fibrosis. Eur. J. Biochem. 168, 57-68 (1987).
57. Kesimer M, Scull M, Brighton B etal. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: A possible role in innate defense. FASEB J. 23, 1858-1868 (2009).
58. Roberts KL, Shelton H, Scull M, Pickles R, Barclay WS. Lack of transmission of a human influenza virus with avian receptor specificity between ferrets is not due to decreased virus shedding but rather a lower infectivity invivo. J. Gen. Virol. 92, 1822-1831 (2011).
59. LeVine AM, Whitsett JA. Pulmonary collectins and innate host defense of the lung. Microbes Infect. 3, 161-166 (2001).
60. Benne CA, Benaissa-Trouw B, van Strijp JA, Kraaijeveld CA, van Iwaarden JF. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur. J. Immunol. 27, 886-890 (1997).
61. Crouch EC. Surfactant protein-D and pulmonary host defense. Respir. Res. 1, 93-108 (2000).
62. Hartshorn KL, Webby R, White MR etal. Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir. Res. 9, 65 (2008).
63. Hillaire ML, van Eijk M, van Trierum SE etal. Assessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses invitro. PLoS One 6, E25005 (2011).
64. Hartshorn KL, Sastry K, Brown D etal. Conglutinin acts as an opsonin for influenza A viruses. J. Immunol. 151, 6265-6273 (1993).
65. Job ER, Deng YM, Tate MD etal. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies. J. Immunol. 185, 4284-4291 (2010).
66. Qi L, Kash JC, Dugan VG etal. The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding. Virology 412, 426-434 (2011).
67. van Eijk M, White MR, Crouch EC etal. Porcine pulmonary collectins show distinct interactions with influenza A viruses: Role of the N-linked oligosaccharides in the carbohydrate recognition domain. J. Immunol. 171, 1431-1440 (2003).
68. Choi YK, Nguyen TD, Ozaki H etal. Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J. Virol. 79, 10821-10825 (2005).
69. Ling MT, Tu W, Han Y etal. Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection. J. Infect. Dis. 205, 44-53 (2012).
70. Van Pottelberge GR, Bracke KR, Pauwels NS etal. COPD is associated with reduced pulmonary interstitial expression of Pentraxin-3. Eur. Respir. J. doi:10.1183/09031936.00138110 (2011) (Epub ahead of print).
71. Steinhauer DA. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258, 1-20 (1999).
72. Stieneke-Grober A, Vey M, Angliker H etal. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11, 2407-2414 (1992).
73. Okumura Y, Takahashi E, Yano M etal. Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication. J. Virol. 84, 5089-5096 (2010).
74. Kido H, Okumura Y, Takahashi E etal. Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure. Biochim. Biophys. Acta. 1824, 186-194 (2012).
75. Bertram S, Glowacka I, Steffen I, Kuhl A, Pohlmann S. Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev. Med. Virol. 20, 298-310 (2010). n Provides an overview of hemagglutinin cleavage by transmembrane proteases.
76. Kido H, Okumura Y, Yamada H, Le TQ, Yano M. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. Curr. Pharm. Des. 13, 405-414 (2007).
77. Murakami M, Towatari T, Ohuchi M etal. Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus. Eur. J. Biochem. 268, 2847-2855 (2001).
78. Takahashi M, Sano T, Yamaoka K etal. Localization of human airway trypsin-like protease in the airway: An immunohistochemical study. Histochem. Cell Biol. 115, 181-187 (2001).
79. Fodor E, Smith M. The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex. J. Virol. 78, 9144-9153 (2004).
80. Deng T, Engelhardt OG, Thomas B etal. Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex. J. Virol. 80, 11911-11919 (2006).
81. Wang P, Palese P, O'Neill RE. The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J. Virol. 71, 1850-1856 (1997).
82. Boulo S, Akarsu H, Lotteau V etal. Human importin alpha and RNA do not compete for binding to influenza A virus nucleoprotein. Virology. 409, 84-90 (2011).
83. Melen K, Fagerlund R, Franke J etal. Importin alpha nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein. J. Biol. Chem. 278, 28193-28200 (2003).
84. Gabriel G, Klingel K, Otte A etal. Differential use of importin-alpha isoforms governs cell tropism and host adaptation of influenza virus. Nat. Commun. 2, 156 (2011).
85. Cox RJ, Brokstad KA, Ogra P. Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand. J. Immunol. 59, 1-15 (2004).
86. Tamura S, Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J. Infect. Dis. 57, 236-247 (2004).
87. García-Sastre A. Induction and evasion of type I interferon responses by influenza viruses. Virus Res. 162, 12-18 (2011). n Discusses the evasion by influenza viruses from type I interferon responses during infection.
88. Munster VJ, de Wit E, van den Brand JM etal. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325, 481-483 (2009).
89. van den Brand JM, Stittelaar KJ, Van Amerongen G etal. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J. Infect. Dis. 201, 993-999 (2010).
90. van den Brand JMA, Stittelaar KJ, Leijten LME etal. Modification of the ferret model for pneumonia from seasonal human influenza A virus infection. Vet. Pathol. doi:10.1177/0300985811429812 (2011) (Epub ahead of print).
91. Bodewes R, Kreijtz JH, Van Amerongen G etal. Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Am. J. Pathol. 179, 30-36 (2011).
92. Lipatov AS, Kwon YK, Pantin-Jackwood MJ, Swayne DE. Pathogenesis of H5N1 influenza virus infections in mice and ferret models differs according to respiratory tract or digestive system exposure. J. Infect. Dis. 199, 717-725 (2009).
93. Zitzow LA, Rowe T, Morken T etal. Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J. Virol. 76, 4420-4429 (2002).
94. Maines TR, Lu XH, Erb SM etal. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79, 11788-11800 (2005).
95. Shinya K, Makino A, Hatta M etal. Subclinical brain injury caused by H5N1 influenza virus infection. J. Virol. 85, 5202-5207 (2011).
96. Gustin KM, Belser JA, Wadford DA etal. Influenza virus aerosol exposure and analytical system for ferrets. Proc. Natl Acad. Sci. USA 108, 8432-8437 (2011).
97. Reperant LA, van de Bildt MW, Van Amerongen G etal. Marked endotheliotropism of highly pathogenic avian influenza virus H5N1 following intestinal inoculation in cats. J. Virol. 86(2), 1158-1165. (2011).